Stanley Black & Decker reported Q2 results on July 29 — and the shorts who spent all of July covering are now rebuilding, adding a sharp intraday twist to what had been a clean pre-earnings derisking story.
The positioning reversal is the most striking data point of the week. Short interest jumped 7.1% in a single session on July 28, rising back to 6.36 million shares — 4.1% of the free float. That snaps a month-long covering trend that had pushed SI down nearly 29% from its late-June peak near 8.1 million shares. The one-week change is now a more modest 3.5% increase, meaning most of that fresh shorting arrived in one day. The borrow market offers no resistance to the new position-building: availability runs at 754% — more than seven shares available to lend for every one already borrowed — and cost to borrow is a negligible 0.45%, actually down 19% on the week from already low levels. These are not the conditions that create a squeeze; they are conditions that make adding short exposure frictionless. Options traders are less alarmed than the SI move implies. The put/call ratio is 0.17, sitting slightly below its 20-day average of 0.18, close to its 52-week low of 0.15. Demand for downside protection has not spiked alongside the fresh shorting — a meaningful divergence.
The Street remains cautious rather than bearish on . The consensus mean price target is $92.63, which is modestly below the current price of $94.19 — the stock has effectively traded through the average analyst target. The most recent action of note came from Wells Fargo in mid-June, lifting its target to $90 while holding Equal-Weight, and Morgan Stanley trimmed its target to $84 in late May. JP Morgan's Underweight rating with a $75 target is the clear outlier on the bear side. Barclays stands as the lone Overweight with a $95 target, essentially at current levels. The analyst recommendation difference factor score ranks in the 100th percentile — an unusual reading suggesting the consensus is skewed toward the bullish end relative to the broader market, even if individual targets lag the price. The EV/EBITDA multiple is around 11x, broadly stable over the past month, while P/E has compressed slightly to 16x. Value remains the most compelling pillar in the ORTEX score framework; quality and growth continue to lag peer averages.
Institutional ownership is broadly supportive and incremental. Capital Research added roughly 122,000 shares, BlackRock added 155,000, and T. Rowe Price added 203,000 — all as of the June 30 reporting window. The increases are not dramatic in percentage terms but represent consistent accumulation from the three of the four largest holders. Insider activity over the past 90 days reflects net awards and routine sell-to-cover transactions rather than discretionary buying. CEO Donald Allan and incoming President Chris Nelson both received share awards and sold modest blocks in late June and early July to cover tax obligations, a pattern typical of equity compensation settlements rather than a directional view on the stock.
Peer context frames the week well. IR gained 6.9% and CNH rose 10.5% over the week, with ITW adding 8.5%. SWK's 6.8% weekly gain holds its own against the group but trails the stronger performers — suggesting the Q2 report did not deliver a breakout relative to the sector's broad move. The short score has been drifting higher this week, reaching 41.8 from 38.7 on July 23, which remains a middling reading but confirms the directional shift in short positioning.
The key question heading into next week is whether the single-session short rebuild on July 28 extends further — or whether it proves an overreaction to the earnings print that fades as the borrow market's ample availability absorbs any momentum.
See the live data behind this article on ORTEX.
Open SWK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
